Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.

Zhou T, Li Y, Yang L, Tang T, Zhang L, Shi J.

Biomed Res Int. 2017;2017:2603685. doi: 10.1155/2017/2603685. Epub 2017 Apr 13.

2.

Laser Capture Microdissection of Pancreatic Acinar Cells to Identify Proteomic Alterations in a Murine Model of Caerulein-Induced Pancreatitis.

Shapiro JP, Komar HM, Hancioglu B, Yu L, Jin M, Ogata Y, Hart PA, Cruz-Monserrate Z, Lesinski GB, Conwell DL.

Clin Transl Gastroenterol. 2017 Apr 13;8(4):e89. doi: 10.1038/ctg.2017.15.

3.

SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer.

Harris NLE, Vennin C, Conway JRW, Vine KL, Pinese M, Cowley MJ, Shearer RF, Lucas MC, Herrmann D, Allam AH, Pajic M, Morton JP; Australian Pancreatic Cancer Genome Initiative, Biankin AV, Ranson M, Timpson P, Saunders DN.

Oncogene. 2017 Jul 27;36(30):4288-4298. doi: 10.1038/onc.2017.63. Epub 2017 Mar 27.

4.

Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.

Jumper N, Hodgkinson T, Paus R, Bayat A.

PLoS One. 2017 Mar 3;12(3):e0172955. doi: 10.1371/journal.pone.0172955. eCollection 2017.

5.

Increased expression of S100A6 promotes cell proliferation in gastric cancer cells.

Wang XH, Du H, Li L, Shao DF, Zhong XY, Hu Y, Liu YQ, Xing XF, Cheng XJ, Guo T, Li S, Li ZY, Bu ZD, Wen XZ, Zhang LH, Ji JF.

Oncol Lett. 2017 Jan;13(1):222-230. doi: 10.3892/ol.2016.5419. Epub 2016 Nov 22.

6.

Elevated S100A6 (Calcyclin) enhances tumorigenesis and suppresses CXCL14-induced apoptosis in clear cell renal cell carcinoma.

Lyu XJ, Li HZ, Ma X, Li XT, Gao Y, Ni D, Shen DL, Gu LY, Wang BJ, Zhang Y, Zhang X.

Oncotarget. 2015 Mar 30;6(9):6656-69.

7.

Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.

Zhu J, Nie S, Wu J, Lubman DM.

J Proteome Res. 2013 Jun 7;12(6):2791-804. doi: 10.1021/pr400139c. Epub 2013 May 29.

8.

Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges.

Pan S, Brentnall TA, Kelly K, Chen R.

Proteomics. 2013 Feb;13(3-4):710-21. doi: 10.1002/pmic.201200319. Epub 2013 Jan 7. Review.

9.

Quantitative proteomic study of human lung squamous carcinoma and normal bronchial epithelial acquired by laser capture microdissection.

Xu Y, Cao LQ, Jin LY, Chen ZC, Zeng GQ, Tang CE, Li GQ, Duan CJ, Peng F, Xiao ZQ, Li C.

J Biomed Biotechnol. 2012;2012:510418. doi: 10.1155/2012/510418. Epub 2012 Feb 28.

10.

The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreas.

Kwon RS, Simeone DM.

Int J Proteomics. 2011;2011:413646. doi: 10.1155/2011/413646. Epub 2011 Oct 24.

11.

Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.

Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC, Reis EM.

Mol Cancer. 2011 Nov 13;10:141. doi: 10.1186/1476-4598-10-141.

12.

Tetracycline-inducible protein expression in pancreatic cancer cells: effects of CapG overexpression.

Tonack S, Patel S, Jalali M, Nedjadi T, Jenkins RE, Goldring C, Neoptolemos J, Costello E.

World J Gastroenterol. 2011 Apr 21;17(15):1947-60. doi: 10.3748/wjg.v17.i15.1947.

13.

Microproteomics: quantitative proteomic profiling of small numbers of laser-captured cells.

Roulhac PL, Ward JM, Thompson JW, Soderblom EJ, Silva M, Moseley MA 3rd, Jarvis ED.

Cold Spring Harb Protoc. 2011 Feb 1;2011(2):pdb.prot5573. doi: 10.1101/pdb.prot5573. No abstract available.

14.

S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

Wang XH, Zhang LH, Zhong XY, Xing XF, Liu YQ, Niu ZJ, Peng Y, Du H, Zhang GG, Hu Y, Liu N, Zhu YB, Ge SH, Zhao W, Lu AP, Li JY, Ji JF.

Am J Pathol. 2010 Aug;177(2):586-97. doi: 10.2353/ajpath.2010.091217. Epub 2010 Jun 25.

15.

Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3.

Bianchi C, Bombelli S, Raimondo F, Torsello B, Angeloni V, Ferrero S, Di Stefano V, Chinello C, Cifola I, Invernizzi L, Brambilla P, Magni F, Pitto M, Zanetti G, Mocarelli P, Perego RA.

Am J Pathol. 2010 Apr;176(4):1660-70. doi: 10.2353/ajpath.2010.090402. Epub 2010 Feb 18.

16.

Characterization of Molecular Markers Indicative of Cervical Cancer Progression.

Arnouk H, Merkley MA, Podolsky RH, Stöppler H, Santos C, Alvarez M, Mariategui J, Ferris D, Lee JR, Dynan WS.

Proteomics Clin Appl. 2009 May 5;3(5):516-527.

17.

S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility.

Nedjadi T, Kitteringham N, Campbell F, Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos JP, Costello E.

Br J Cancer. 2009 Oct 6;101(7):1145-54. doi: 10.1038/sj.bjc.6605289. Epub 2009 Sep 1.

18.

Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites.

Weinberger PM, Merkley M, Lee JR, Adam BL, Gourin CG, Podolsky RH, Haffty BG, Papadavid E, Sasaki C, Psyrri A, Dynan WS.

Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):694-703. doi: 10.1001/archoto.2009.78.

19.

A tumor sorting protocol that enables enrichment of pancreatic adenocarcinoma cells and facilitation of genetic analyses.

Boyd ZS, Raja R, Johnson S, Eberhard DA, Lackner MR.

J Mol Diagn. 2009 Jul;11(4):290-7. doi: 10.2353/jmoldx.2009.080124. Epub 2009 May 21.

20.

Proteomic analyses of pancreatic cyst fluids.

Ke E, Patel BB, Liu T, Li XM, Haluszka O, Hoffman JP, Ehya H, Young NA, Watson JC, Weinberg DS, Nguyen MT, Cohen SJ, Meropol NJ, Litwin S, Tokar JL, Yeung AT.

Pancreas. 2009 Mar;38(2):e33-42. doi: 10.1097/MPA.0b013e318193a08f.

Supplemental Content

Support Center